These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9345429)

  • 1. T cell response to two immunodominant proteolipid protein (PLP) peptides in multiple sclerosis patients and healthy controls.
    Pelfrey CM; Tranquill LR; Vogt AB; McFarland HF
    Mult Scler; 1996 Apr; 1(5):270-8. PubMed ID: 9345429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel T cell epitope of human proteolipid protein (residues 40-60) recognized by proliferative and cytolytic CD4+ T cells from multiple sclerosis patients.
    Pelfrey CM; Trotter JL; Tranquill LR; McFarland HF
    J Neuroimmunol; 1993 Jul; 46(1-2):33-42. PubMed ID: 7689593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of proteolipid protein (PLP)-specific T cells in multiple sclerosis: identification of PLP 95-116 as an HLA-DR2,w15-associated determinant.
    Ohashi T; Yamamura T; Inobe J; Kondo T; Kunishita T; Tabira T
    Int Immunol; 1995 Nov; 7(11):1771-8. PubMed ID: 8580075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones.
    Meinl E; Weber F; Drexler K; Morelle C; Ott M; Saruhan-Direskeneli G; Goebels N; Ertl B; Jechart G; Giegerich G
    J Clin Invest; 1993 Dec; 92(6):2633-43. PubMed ID: 7504690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of gender on T-cell proliferative responses to myelin proteolipid protein antigens in patients with multiple sclerosis and controls.
    Greer JM; Csurhes PA; Pender MP; McCombe PA
    J Autoimmun; 2004 Jun; 22(4):345-52. PubMed ID: 15120759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a second T cell epitope of human proteolipid protein (residues 89-106) recognized by proliferative and cytolytic CD4+ T cells from multiple sclerosis patients.
    Pelfrey CM; Trotter JL; Tranquill LR; McFarland HF
    J Neuroimmunol; 1994 Sep; 53(2):153-61. PubMed ID: 7520919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans.
    Markovic-Plese S; Fukaura H; Zhang J; al-Sabbagh A; Southwood S; Sette A; Kuchroo VK; Hafler DA
    J Immunol; 1995 Jul; 155(2):982-92. PubMed ID: 7541828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell recognition of myelin proteolipid protein and myelin proteolipid protein peptides in the peripheral blood of multiple sclerosis and control subjects.
    Trotter JL; Pelfrey CM; Trotter AL; Selvidge JA; Gushleff KC; Mohanakumar T; McFarland HF
    J Neuroimmunol; 1998 Apr; 84(2):172-8. PubMed ID: 9628460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surges of increased T cell reactivity to an encephalitogenic region of myelin proteolipid protein occur more often in patients with multiple sclerosis than in healthy subjects.
    Pender MP; Csurhes PA; Greer JM; Mowat PD; Henderson RD; Cameron KD; Purdie DM; McCombe PA; Good MF
    J Immunol; 2000 Nov; 165(9):5322-31. PubMed ID: 11046067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [T cell immunity to proteolipid protein (PLP) in multiple sclerosis (MS): identification of DR2-associated PLP determinants and conserved TCR CDR3 motifs].
    Kondo T; Ohashi T
    Nihon Rinsho; 1994 Nov; 52(11):2940-5. PubMed ID: 7527867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences between T-cell reactivities to major myelin protein-derived peptides in opticospinal and conventional forms of multiple sclerosis and healthy controls.
    Minohara M; Ochi H; Matsushita S; Irie A; Nishimura Y; Kira J
    Tissue Antigens; 2001 May; 57(5):447-56. PubMed ID: 11556969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hla-DR2-restricted responses to proteolipid protein 95-116 peptide cause autoimmune encephalitis in transgenic mice.
    Kawamura K; Yamamura T; Yokoyama K; Chui DH; Fukui Y; Sasazuki T; Inoko H; David CS; Tabira T
    J Clin Invest; 2000 Apr; 105(7):977-84. PubMed ID: 10841661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelin basic protein-specific T-cell responses in identical twins discordant or concordant for multiple sclerosis.
    Martin R; Voskuhl R; Flerlage M; McFarlin DE; McFarland HF
    Ann Neurol; 1993 Oct; 34(4):524-35. PubMed ID: 7692808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.
    Valli A; Sette A; Kappos L; Oseroff C; Sidney J; Miescher G; Hochberger M; Albert ED; Adorini L
    J Clin Invest; 1993 Feb; 91(2):616-28. PubMed ID: 7679413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivity pattern and cytokine profile of T cells primed by myelin peptides in multiple sclerosis and healthy individuals.
    Tejada-Simon MV; Hong J; Rivera VM; Zhang JZ
    Eur J Immunol; 2001 Mar; 31(3):907-17. PubMed ID: 11241296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TCR repertoire to proteolipid protein (PLP) in multiple sclerosis (MS): homologies between PLP-specific T cells and MS-associated T cells in TCR junctional sequences.
    Kondo T; Yamamura T; Inobe J; Ohashi T; Takahashi K; Tabira T
    Int Immunol; 1996 Jan; 8(1):123-30. PubMed ID: 8671596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals.
    Martin R; Jaraquemada D; Flerlage M; Richert J; Whitaker J; Long EO; McFarlin DE; McFarland HF
    J Immunol; 1990 Jul; 145(2):540-8. PubMed ID: 1694881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP).
    Kaushansky N; Altmann DM; David CS; Lassmann H; Ben-Nun A
    J Neuroinflammation; 2012 Feb; 9():29. PubMed ID: 22316121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell response to myelin basic protein in the context of the multiple sclerosis-associated HLA-DR15 haplotype: peptide binding, immunodominance and effector functions of T cells.
    Vergelli M; Kalbus M; Rojo SC; Hemmer B; Kalbacher H; Tranquill L; Beck H; McFarland HF; De Mars R; Long EO; Martin R
    J Neuroimmunol; 1997 Aug; 77(2):195-203. PubMed ID: 9258250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.
    Zhang J; Markovic-Plese S; Lacet B; Raus J; Weiner HL; Hafler DA
    J Exp Med; 1994 Mar; 179(3):973-84. PubMed ID: 7509366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.